Among the companies with shares expected to actively trade in
Tuesday's session are Tiptree Financial Inc. (TIPT), Fortegra
Financial Corp. (FRF) and Kate Spade & Co. (KATE).
Financial holding company Tiptree agreed to acquire Fortegra in
an all-cash deal that values the insurance-services company at
about $200 million. Shares of Tiptree rose 11.2% to $8.03 in
premarket trading. Fortegra shares surged 40.6% to $9.87.
Kate Spade said its second-quarter loss narrowed, driven by a
surge in demand as customers continued to snatch up its
namesake-brand handbags and accessories. Shares climbed 7.9% to
$41.94 premarket.
Intercept Pharmaceuticals Inc. (ICPT) on Monday released
additional results of a closely watched clinical trial suggesting
that an experimental liver-disease drug may have had a more benign
effect on patients' cholesterol levels than initially thought.
Shares jumped 46.8% to $348.21 premarket.
The Food and Drug Administration on Monday approved Exact
Sciences Inc.'s (EXAS) Cologuard DNA test to screen for colon
cancer in people with a lower risk of developing the disease, the
first such test of its kind to be cleared by U.S. regulators.
Shares gained 5.1% to $17.98 premarket.
Valspar Corp. (VAL) said its fiscal third-quarter earnings rose
4.3% as a strong performance in the coatings segment and higher
volumes drove up sales. The company also raised its outlook for the
year. Shares rose 2.1% to $79.50 premarket.
Schlumberger Ltd. (SLB) said U.S. and European economic
sanctions against Russia over the Ukraine crisis will have a
limited impact on the company's financial results for the third
quarter. It currently estimates the impact on earnings at three
cents a share.
Tribune Media Co. (TRBAA) said its second-quarter profit rose
25% on revenue growth that was buoyed by recent acquisitions.
Meanwhile, Tribune Publishing Co. (TPUB), which was recently spun
off from Tribune Media, said second-quarter earnings fell on a 3.8%
decline in revenue.
Watchlist:
Allergan Inc. (AGN) and Valeant Pharmaceuticals Inc. (VRX) said
they received a second request from the Federal Trade Commission
seeking information about Valeant and investor William Ackman's
takeover bid. The request pushes back the waiting period by 30
days.
Caesars Entertainment Corp.'s (CZR) second-quarter loss widened
as the casino operator said strong Las Vegas results were offset by
persistent softness in Atlantic City and regional markets.
A pair of Brazilian companies unveiled a $625 million offer
Monday for Chiquita Brands International Inc. (CQB), seeking to
thwart the U.S. banana company's plans to merge with Ireland's
Fyffes PLC (FFY.DB).
ICU Medical Inc.'s (ICUI) second-quarter earnings fell 20% as
the medical-products maker reported higher operating expenses and
lower domestic sales.
Wireless services provider NII Holdings Inc. (NIHD) said Monday
it will likely file for Chapter 11 bankruptcy. The company said it
has had "productive discussions" with noteholders about a potential
consensual restructuring.
Nuance Communications Inc. (NUAN) posted fiscal third-quarter
revenue below expectations as the company's loss widened.
Opko Health Inc.'s (OPK) advanced clinical trial on the use of
Rayaldee to treat secondary hyperparathyroidism in patients with
Stage 3 or 4 chronic kidney disease and vitamin D insufficiency met
the study's primary endpoints. The company also reported its
second-quarter net loss rose sharply on acquisition and research
and development costs.
Rackspace Hosting Inc.'s (RAX) second-quarter earnings edged up
as revenue growth helped offset higher operating expenses.
Write to Tom Rojas at tom.rojas@wsj.com and Maria Armental at
maria.armental@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires